Adverse effect of expectorants, initial encounter

This code signifies an undesirable or harmful reaction experienced by a patient due to the therapeutic use of an expectorant medication. This reaction occurred during the initial phase of treatment or exposure to the drug. It indicates that the expectorant, when administered correctly, still produced an adverse outcome.

Apply this code when a patient presents with symptoms or conditions directly attributable to an expectorant, such as guaifenesin or acetylcysteine, and it's the first time they are being treated for this specific adverse event. This includes situations where the patient experiences side effects like nausea, vomiting, dizziness, or allergic reactions after taking the prescribed or over-the-counter expectorant.

• Always sequence this code after the code(s) for the specific manifestation of the adverse effect.
• Ensure documentation clearly links the patient's symptoms to the expectorant and specifies it as an adverse effect, not poisoning or underdosing.
• Verify that the encounter is indeed the "initial encounter" for this specific adverse reaction to the expectorant.